M. Gu et al. / Bioorg. Med. Chem. 18 (2010) 3012–3019
3017
solvent was removed to afford 6, 6 was dissolved in chloroform
(3 ml) at 0 °C, then JA-OSu (35 mg, 0.114 mmol) and TEA (68 l,
2H), 1.25 (m, 3H), 0.98 (m, 2H), 0.02 (s, 9H); ESI-LRMS (m/z):
C
26H36N2NaO4Si: 491.2 [M+Na]+.
l
0.50 mmol) was added. The reaction was stirred for 12 h at room
temperature. The solvent was concentrated and HCl (1 N) was
added to acidify the mixture to pH 2–3, the reaction mixture was
extracted with EtOAc (3 ꢀ 20 ml). The combined organic extracts
were washed with saturated brine, dried over anhydrous Na2SO4.
The solvent was concentrated and the residue was purified with
silica gel chromatography (CH3OH/CHCl3, 1:50) to afford 7 as a pale
yellow gum (50 mg, 73%). 1H NMR (300 MHz, CDCl3): d = 8.18 (s,
1H), 8.14 (d, J = 8.1 Hz, 1H), 6.87 (d, J = 8.4 Hz, 1H), 6.70 (s, 1H),
6.18 (s, 1H), 5.41 (m, 1H), 5.26 (m, 1H), 4.26 (t, J = 4.5 Hz, 2H),
3.88 (t, J = 4.5 Hz, 2H), 3.67 (m, 12H), 3.51 (t, J = 4.8 Hz, 2H), 3.42
(q, J = 5.1 Hz, 2H), 3.33 (t, J = 4.5 Hz, 2H), 2.50 (m, 1H), 2.31 (m,
4H), 2.05 (m, 7H), 1.82 (m, 1H), 1.36 (m, 1H), 0.93 (t, J = 7.8 Hz,
3H); ESI-LRMS (m/z): C33H46F3N7NaO8: 748.3 [M+Na]+.
5.2.6. Compound 10
Let 9 (25 mg, 0.05 mmol) and 4 (30 mg, 0.05 mmol) dissolved in
chloroform (2 ml) at 0 °C, then added NaHCO3 (10 mg, 0.12 mmol).
The reaction mixture was stirred for 12 h at room temperature. The
solvent was concentrated and HCl (1 N) was added to acidify the
mixture to pH 2–3, the reaction mixture was extracted with EtOAc
(3 ꢀ 20 ml). The combined organic extracts were washed with
saturated brine, dried over anhydrous Na2SO4. The solvent was
concentrated and the residue was purified with silica gel chroma-
tography (CH3OH/CHCl3, 1:80) to afford 10 as a pale yellow gum
(42 mg, 85%). 1H NMR (300 MHz, CDCl3): d = 8.19 (d, J = 8.4 Hz,
1H), 8.03 (t, J = 5.1 Hz, 1H), 7.76 (d, J = 7.5 Hz, 2H), 7.59 (t,
J = 6.3 Hz, 2H), 7.39 (t, J = 7.5 Hz, 2H), 7.29 (t, J = 7.2 Hz, 2H), 6.75
(d, J = 7.8 Hz, 1H), 6.64 (s, 1H), 5.67 (d, J = 7.8 Hz, 1H), 4.92 (s,
1H), 4.42 (t, J = 7.5 Hz, 2H), 4.18 (m, 7H), 3.76 (m, 2H), 3.58 (m,
2H), 3.43 (m, 4H), 3.23 (m, 2H), 1.84 (m, 1H), 1.75 (m, 1H), 1.60
(m, 2H), 1.41 (s, 9H), 1.25 (m, 3H), 0.99 (m, 2H), 0.03 (s, 9H);
ESI-LRMS (m/z): C46H60F3N5NaO10Si: 950.4 [M+Na]+.
5.2.3. PAJA
MeOH (3 ml) was added to a reaction bottle containing 7
(28 mg, 0.039 mmol), then prop-2-ynylamide-biotin (12 mg,
0.041 mmol) and 1 ml 10 mM CuSO4 water solution (0.01 mmol)
were added in. Under the protection of nitrogen, 30 mg/ml sodium
ascorbic solution (280
l
l, 0.042 mmol) was added at last. The reac-
5.2.7. Compound 11
tion was stirred for 12 h at room temperature. After MeOH was re-
moved, the mixture was extracted with EtOAc (3 ꢀ 20 ml). The
combined organic extracts were washed with saturated brine,
dried over anhydrous Na2SO4. The solvent was concentrated and
the residue was purified with silica gel chromatography (CH3OH/
CHCl3, 1:20) to afford probe PAJA as a pale yellow gum (30 mg,
77%). 1H NMR (300 MHz, CDCl3): d = 8.23 (s, 1H), 8.15 (d,
J = 8.1 Hz, 1H), 7.72 (s, 1H), 7.34 (s, 1H), 6.90 (d, J = 7.5 Hz, 1H),
6.71 (s, 1H), 6.50 (m, 1H), 6.39 (s, 1H), 5.73 (s, 1H), 5.42 (m, 1H),
5.28 (m, 1H), 4.48 (m, 2H), 4.26 (m, 2H), 3.84 (m, 2H), 3.60 (m,
8H), 3.48 (m, 2H), 3.42 (m, 2H), 3.12 (m, 1H), 2.90 (m, 1H), 2.74
(m, 1H), 2.52 (m, 1H), 2.33 (m, 4H), 2.22 (m, 2H), 2.13 (m, 2H),
2.06 (m, 2H), 1.87 (m, 1H), 1.64 (m, 4H), 1.47 (m, 4H), 1.25 (m,
8H), 0.95 (m, 5H); ESI-HRMS (m/z): calcd for C46H65F3N10NaO10S:
1029.4456 [M+Na]+; found 1029.4460. HPLC purity system A:
95.25%; system B: 95.12%.
Compound 10 (42 mg, 0.05 mmol) was dissolved in DMF(0.5 ml),
piperidine (25 ll, 0.25 mmol)wasadded to thesolution, thereaction
mixturewasstirredfor0.5 hat roomtemperature. Thereactionsolu-
tion was diluted by water, mixture was extracted with EtOAc
(3 ꢀ 20 ml). The combined organic extracts were washed with
water, saturated brine, dried over anhydrous Na2SO4. The solvent
was concentrated and the residue was purified with silica gel chro-
matography (CH3OH/CHCl3, 1:20) to afford 11 as a pale yellow
gum (26 mg, 80%). 1H NMR (300 MHz, CDCl3): d = 8.16 (d,
J = 8.1 Hz, 1H), 8.02 (t, J = 5.4 Hz, 1H), 6.85 (d, J = 8.4 Hz, 1H), 6.65
(s, 1H), 5.13 (s, 1H), 4.23 (m, 2H), 4.15 (m, 2H), 3.88 (m, 2H), 3.67
(m, 2H), 3.58 (m, 2H), 3.45 (m, 2H), 3.37 (m, 3H), 3.26 (m, 2H), 1.73
(m, 2H), 1.63 (m, 6H), 1.39 (s, 9H), 0.95 (m, 2H), 0.02 (s, 9H); ESI-
LRMS (m/z): C31H50F3N5NaO8Si: 728.3 [M+Na]+.
5.2.8. Compound 12
Compound 11 (24 mg, 0.034 mmol), JA-Ile (10 mg, 0.031 mmol),
DCC (20 mg, 0.097 mmol) and 1-hydroxybenzotriazole (HOBt)
(10 mg, 0.074 mmol) were dissolved in DCM (5 ml), then TEA
5.2.4. Compound 8
Fmoc-Lys(Z)-OH (502 mg, 1 mmol), 2-trimethylsilanyl-ethanol
(180 mg, 1.53 mmol), N0,N0-dicyclohexylcarbodiimide (DCC)
(310 mg, 1.50 mmol) and 4-dimethylamino-pyridine (DMAP)
(100 mg, 0.82 mmol) were dissolved in DCM (10 ml), The reaction
mixture was stirred for 3 h at room temperature. The solvent was
concentrated and HCl (1 N) was added to acidify the mixture to pH
2–3, the reaction mixture was extracted with EtOAc (3 ꢀ 50 ml).
The combined organic extracts were washed with saturated brine,
dried over anhydrous Na2SO4. The solvent was concentrated and
the residue was purified with silica gel chromatography (EtOAc/
petroleum ether, 1:3) to afford 8 as a pale yellow gum (395 mg,
67%). 1H NMR (300 MHz, CDCl3): d = 7.76 (d, J = 7.2 Hz, 2H), 7.60
(d, J = 6.9 Hz, 2H), 7.33 (m, 9H), 5.37 (m, 1H), 5.08 (s, 1H), 4.78
(m, 1H), 4.39 (m, 3H), 4.22 (m, 3H), 3.20 (d, J = 6.3 Hz, 2H), 1.85
(m, 1H), 1.65 (m, 2H), 1.56 (m, 2H), 1.39 (m, 2H), 1.01 (m, 2H),
0.06 (s, 9H); ESI-LRMS (m/z): C34H42N2NaO6Si: 625.3 [M+Na]+.
(10 ll, 0.08 mmol) was added, The reaction mixture was stirred
for 12 h at room temperature. The solvent was concentrated and
HCl (1 N) was added to acidify the mixture to pH 2–3, the reaction
mixture was extracted with EtOAc (3 ꢀ 20 ml). The combined or-
ganic extracts were washed with saturated brine, dried over anhy-
drous Na2SO4. The solvent was concentrated and the residue was
purified with silica gel chromatography (CH3OH/CHCl3, 1:100) to
afford 12 as a pale yellow gum (19 mg, 61%). 1H NMR (300 MHz,
CDCl3): d = 8.21 (d, J = 8.1 Hz, 1H), 8.13 (t, J = 4.8 Hz, 1H), 6.91 (d,
J = 8.4 Hz, 1H), 6.86 (m, 1H), 6.69 (s, 1H), 6.35 (m, 1H), 5.42 (m,
1H), 5.28 (m, 1H), 4.95 (s, 1H), 4.43 (m, 2H), 4.25 (m, 2H), 4.19
(m, 2H), 3.90 (m, 2H), 3.68 (m, 2H), 3.51 (m, 2H), 3.39 (m, 2H),
3.28 (m, 2H), 2.62 (m, 1H), 2.37 (m, 5H), 2.17 (m, 3H), 2.07 (m,
4H), 1.87 (m, 4H), 1.60 (m, 4H), 1.47 (s, 9H), 1.25 (m, 2H), 0.91
(m, 11H), 0.03 (s, 9H); ESI-LRMS (m/z): C49H77F3N6NaO11Si:
1033.4 [M+Na]+.
5.2.5. Compound 9
Compound 8 (80 mg, 0.13 mmol) was dissolved in methanol
(5 ml), Pd/C (8 mg) and a few drops of acetic acid were added in
the solution, the air in the reaction bottle were replaced by hydro-
gen. The reaction was stirred for 3 h at room temperature. The sol-
vent was removed to afford 9 as a gum (50 mg, 80%). 1H NMR
(300 MHz, CDCl3): d = 7.72 (d, J = 7.2 Hz, 2H), 7.53 (d, J = 7.2 Hz,
2H), 7.35 (m, 4H), 4.27 (m, 6H), 2.98 (s, 2H), 1.78 (s, 4H), 1.46 (s,
5.2.9. Compound 13
Compound 11 (15 mg, 0.021 mmol), coronatine (5 mg,
0.016 mmol), DCC (20 mg, 0.097 mmol) and 1-hydroxybenzotria-
zole(HOBt) (10 mg, 0.074 mmol) were dissolved in DCM (5 ml),
then TEA (10 ll, 0.08 mmol) was added, The reaction mixture
was stirred for 12 h at room temperature. The solvent was concen-
trated and HCl (1 N) was added to acidify the mixture to pH 2–3,